What is it about?
The aim of the present study was to introduction of hydroxyapatite/chitosan nanocomposite as a new radiosynovectomy agent with excellent properties.
Photo by Tudor Baciu on Unsplash
Why is it important?
the prepared radiopharmaceutical would be a potential therapeutic agent for use in radiosynovectomy procedure.
Read the Original
This page is a summary of: Design, synthesis and characterization of hydroxyapatite-chitosan nanocomposite radiolabelled with 153Sm as radiopharmaceutical for use in radiosynovectomy, Radiochimica Acta, December 2019, De Gruyter, DOI: 10.1515/ract-2018-3038.
You can read the full text:
The following have contributed to this page